Grotenhuis J A, Bettag W, Fiebach B J, Dabir K
J Neurosurg. 1984 Aug;61(2):231-40. doi: 10.3171/jns.1984.61.2.0231.
Nimodipine was given as an intracarotid slow bolus injection in six patients with subarachnoid hemorrhage (SAH) due to rupture of a cerebral aneurysm, with angiographically demonstrated vasospasm. The patients were followed by serial angiograms for demonstration of the effect of nimodipine on vasospasm. After angiography, all patients were treated with a constant venous infusion of this new calcium antagonist. Although the therapeutic regimen was started only a few hours after onset of vasospasm, there was no change in cerebral vessel caliber detectable on angiograms following the intracarotid injection. Three patients died, two patients finally recovered with neurological deficits due to cerebral ischemia, and one patient with asymptomatic vasospasm remained symptom-free. Although nimodipine may act to prevent cerebral vasospasm after SAH, the authors believe that the intracarotid application is not effective after vasospasm has occurred.
对6例因脑动脉瘤破裂导致蛛网膜下腔出血(SAH)且血管造影显示有血管痉挛的患者,给予尼莫地平颈内动脉缓慢推注。通过连续血管造影观察尼莫地平对血管痉挛的作用。血管造影后,所有患者均持续静脉输注这种新型钙拮抗剂。尽管治疗方案在血管痉挛发作后仅数小时就开始,但颈内动脉注射后血管造影未发现脑血管管径有变化。3例患者死亡,2例患者最终因脑缺血遗留神经功能缺损而康复,1例无症状性血管痉挛患者仍无症状。尽管尼莫地平可能对预防SAH后的脑血管痉挛有作用,但作者认为在血管痉挛发生后颈内动脉应用无效。